Expertise in
14
conditions

Dr. Minesh P. Mehta

Radiation Oncology
Baptist Health Medical Group Oncology LLC
6200 Sw 73 St, 
South Miami, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Expertise in
14
conditions
Baptist Health Medical Group Oncology LLC
6200 Sw 73 St, 
South Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Minesh Mehta is a Radiation Oncologist in South Miami, Florida. Dr. Mehta is highly rated in 14 conditions, according to our data. His top areas of expertise are Glioma, Astrocytoma, Gliomatosis Cerebri, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Mehta is currently accepting new patients.

His clinical research consists of co-authoring 413 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in FL
Hospital Affiliations
Baptist Hospital Of Miami
Languages Spoken
English
Hindi
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
View 1 Less Insurance Carrier -

Locations

BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC
6200 Sw 73 St, South Miami, FL 33143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Procedure, Device, Biological
Study Phase: Phase 2
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
Enrollment Status: Active_not_recruiting
Publish Date: March 21, 2025
Intervention Type: Radiation
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Temozolomide, Depatuxizumab
Study Phase: Phase 3
Proposed Pilot Study of Combined Optune+ Bevacizumab, and Hypofractionated Stereotactic Irradiation for Bevacizumab-Naive Recurrent Glioblastoma
Proposed Pilot Study of Combined Optune+ Bevacizumab, and Hypofractionated Stereotactic Irradiation for Bevacizumab-Naive Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: February 03, 2022
Intervention Type: Device
Study Phase: Not Applicable
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: June 02, 2021
Intervention Type: Device, Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

413 Total Publications

Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trial.
Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trial.
Journal: Neuro-oncology
Published: August 20, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Rupesh R. Kotecha
Radiation Oncology
Expertise in
28
conditions
Dr. Rupesh R. Kotecha
Radiation Oncology

Baptist Health Medical Group Oncology LLC

8900 N Kendall Dr, 
Miami, FL 
 (3.2 miles away)
786-596-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rupesh Kotecha is a Radiation Oncologist in Miami, Florida. Dr. Kotecha is highly rated in 28 conditions, according to our data. His top areas of expertise are Brain Tumor, Astrocytoma, Glioblastoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Kotecha is currently accepting new patients.

Expertise in
31
conditions
Dr. Raphael L. Yechieli
Radiation Oncology
Expertise in
31
conditions
Dr. Raphael L. Yechieli
Radiation Oncology

University Of Miami

1475 Nw 12th Ave, 
Miami, FL 
 (7.8 miles away)
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raphael Yechieli is a Radiation Oncologist in Miami, Florida. Dr. Yechieli has been practicing medicine for over 17 years is highly rated in 31 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Bone Tumor, Gastrostomy, and Gamma Knife Radiosurgery. Dr. Yechieli is currently accepting new patients.

Expertise in
27
conditions
Dr. Matthew C. Abramowitz
Radiation Oncology
Expertise in
27
conditions
Dr. Matthew C. Abramowitz
Radiation Oncology

University Of Miami

1611 Nw 12 Th Ave, Jackson Memorial Hospital, 
Miami, FL 
 (8.0 miles away)
305-355-5000
Languages Spoken:
English, Hindi, Marathi, Spanish, Swahili
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Abramowitz is a Radiation Oncologist in Miami, Florida. Dr. Abramowitz is highly rated in 27 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Astrocytoma, Gliosarcoma, and Prostatectomy. Dr. Abramowitz is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile